Skip to main content
ZJYL logo

Jin Medical International Ltd. (ZJYL) Stock Price & Analysis

Jin Medical International Ltd. (ZJYL) — MoonshotScore 41/100 (Weak band), calculated Nov 18, 2026. Price $3.34 (-0.60%), as of the Nov 19, 2026 trading session.

Educational signal · not a buy or sell recommendation · How to read this

$3.34 −$0.02 (-0.60%)

Jin Medical International Ltd. · ZJYL · NASDAQ

Jin Medical International Ltd. focuses on designing, developing, manufacturing, and selling wheelchairs and other living aids for individuals with disabilities or impaired mobility. The company operates both in China and internationally, offering products like oxygen concentrators and bathing machines.

Price as of Nov 19, 2026

Key Statistics

41 of 100

MoonshotScore v2 · Jin Medical International (ZJYL)

Weak
Business Quality Solid (63)
Financial Safety Fragile (4)
Valuation Fair (63)
Growth Durability Fading (34)
Momentum Rising (75)
Why this rating? Method, drivers & history

Bands for the MoonshotScore: Exceptional 80-100 · Strong 65-79 · Fair 45-64 · Weak below 45.

  • Business Quality — Is this a genuinely good business?
  • Financial Safety — Could this blow up on me?
  • Valuation — Am I paying a fair price?
  • Growth Durability — Is the growth real and likely to last?
  • Momentum — Is the market already moving on this?
The ten-second read ·

Strong price action running well ahead of the business — a fragile balance sheet underneath; a move to treat with suspicion, not chase. The score also carries a risk penalty for reported profit not backed by cash flow. Business Quality: Solid; Financial Safety: Fragile; Valuation: Fair; Growth Durability: Fading; Momentum: Rising.

  • quarterly revenue $9M (Q2 FY2026, quarter ended Mar 31, 2026)
  • Altman Z 2.26 · Piotroski F 3
  • ROE 3.9% · ROA 2.1% · current ratio 1.95 · earnings yield 4.3% · free-cash-flow yield -25.4%

Holding back: balance-sheet strain, soft growth

Helping: positive momentum

What has the MoonshotScore done over time?

MoonshotScore snapshots recorded for ZJYL (52 recorded, newest six shown)
RecordedScoreBand
42Weak
41Weak
41Weak
41Weak
41Weak
41Weak

Daily score refresh is delayed. This is the last recorded calculation.

Calculation uses the most recent completed US trading session. Live price changes do not update the score immediately.

Computed · How the MoonshotScore is computed →

Price & valuation

As of
MeasureValue
Latest provided price$3.34
Change on the day-0.60%
Price / earnings (trailing)23.08
Shares traded on the day30.7K

Price & events

Other perspectives

Council score for Jin Medical International (ZJYL): perspectives

Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.

5-Factor Breakdown

Business Quality Moderate
Financial Safety Negative
Valuation Moderate
Growth Durability Weak
Momentum Moderate

Legends Council

4 lenses, 0 current

AI simulations built from the named investors' published principles. Not affiliated with, endorsed by, or the opinion of these individuals. How these lenses are built

Dalio-style lens (simulated) Ray Dalio Favorable read
Englander-style lens (simulated) Izzy Englander Neutral read
Klarman-style lens (simulated) Seth Klarman Unfavorable read
Moon AI lens (model) Neutral read

Read on: Nov 15, 2026 · older than the 27 hours refresh window; not a current reading

Munger's Mindset

Balance Sheet & Valuation · historical

Financial Health Negative
Margin of Safety Fairly Valued
Profit Margin Neutral
Revenue Growth Negative
Debt/Equity Weak
ROE Weak
Gross Margin Neutral

Read on: Sep 11, 2026 · older than the 27 hours refresh window; not a current reading

How to read these bars and different assessments

Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.

Bars show each model's ordered assessment on its own scale, not a probability or a comparable investment return. The adjacent words give the assessment; more filled segments indicate a stronger model reading.

On Sep 11, 2026, the Munger lens read the price at that time as fairly valued against its own estimate of value.

Readings on this page are from Nov 20, 2026, except a card that shows its own read date.

1 · What is it?

What is Jin Medical International (ZJYL), and what does it report?

Short answer · as of

A current FMP business description is unavailable; the listing and provider classification below are the available identity facts. Jin Medical International Ltd. (ZJYL) is listed on NASDAQ. It employs 273 people. In Q2 FY2026 it reported revenue of $9M and net income of -$107,735.

2 · Latest results

What do the latest results show for Jin Medical International (ZJYL)?

Short answer · as of

The most recent reported quarter, Q2 FY2026, carried revenue of $9M.

Quarterly income statement — 4 quarters
Revenue, net income and earnings per share by quarter
PeriodRevenueNet incomeEPS
Q2 FY2026$9M-$107,735-$0.01 (diluted)
Q4 FY2025$11M$1M$0.16 (diluted)
Q2 FY2025$10M-$89,008-$0.01 (diluted)
Q4 FY2024$13M$2M$0.24 (diluted)
3 · Financial strengths and risks

What are the financial strengths and risks for Jin Medical International (ZJYL)?

Short answer · as of

The MoonshotScore pillars rate positive momentum as strengths. What is holding it back is balance-sheet strain, soft growth. The distress and quality screens read Altman Z 2.26 · Piotroski F 3. Trailing ratios: ROE 3.9% · ROA 2.1% · current ratio 1.95 · earnings yield 4.3% · free-cash-flow yield -25.4%.

5 · Peer comparison

How does Jin Medical International compare with its peers?

Short answer

Jin Medical International's score ranks 13th of 13 in the bounded comparison shown, against 12 same-model peers. These are company scores, not expected investment returns. The set lists named competitors first, then companies in the same data-provider industry classification closest in market value; that classification is the provider's, not our judgment of business similarity.

Peer set — price, market value and MoonshotScore
CompanyPriceMarket valueScore
ResMed Inc. (RMD) Same industry, near in market value$242.61 Nov 18, 2026$34.1B95 5-pillar Nov 18, 2026
Intuitive Surgical, Inc. (ISRG) Same industry, near in market value$420.95 Nov 18, 2026$146B94 5-pillar Nov 18, 2026
West Pharmaceutical Services, Inc. (WST) Same industry, near in market value$404.02 Nov 18, 2026$28.1B92 5-pillar Nov 18, 2026
Haemonetics Corporation (HAE) Same industry, near in market value$120.37 Nov 19, 2026$5.48B83 5-pillar Nov 18, 2026
Alcon Inc. (ALC) Same industry, near in market value$74.52 Nov 19, 2026$35.8B80 5-pillar Nov 18, 2026
AptarGroup, Inc. (ATR) Same industry, near in market value$140.34 Nov 19, 2026$8.90B77 5-pillar Nov 18, 2026
Medline Inc. Class A Common Stock (MDLN) Same industry, near in market value$37.84 Nov 19, 2026$49.8B72 5-pillar Nov 18, 2026
Repligen Corporation (RGEN) Same industry, near in market value$170.29 Nov 19, 2026$10.9B71 5-pillar Nov 18, 2026
Avantor, Inc. (AVTR) Same industry, near in market value$15.12 Nov 19, 2026$10.3B71 5-pillar Nov 18, 2026
Becton, Dickinson and Company (BDX) Same industry, near in market value$212.73 Nov 19, 2026$57.9B68 5-pillar Nov 18, 2026
Teleflex Incorporated (TFX) Same industry, near in market value$163.40 Nov 19, 2026$6.48B61 5-pillar Nov 18, 2026
Baxter International Inc. (BAX) Same industry, near in market value$25.39 Nov 19, 2026$13.1B57 5-pillar Nov 18, 2026
Jin Medical International (ZJYL) — this page$3.34—41

Only 5-pillar scores are ranked together. Other models are not directly comparable. Price and score dates are shown separately; market-value dates are unavailable.

The records behind this page

Who holds the shares?

Institutional ownership reported through 13F filings.

Tracked investors

Which of the 16 named investors we follow held ZJYL in their latest 13F filing, and what they did against the filing before it.

None of the 16 tracked investors reported ZJYL in their latest 13F filing.

See all tracked investor portfolios

How to read these figures

These filings arrive after the quarter ends. Names appear as the provider lists them, not as a verified ranking, and without filing dates. Related managers can appear separately, so their shares are not added together. Tracked investors: each fund's own latest 13F, so funds that have not filed the newest quarter yet show their previous one; weight is the share of the fund's reported 13F value.

What has been published about Jin Medical International (ZJYL)?

Read these with our analysis →

Jin Medical International Stock: Key Questions Answered

These answers are editorial: 1 of these 9 answers is drawn from the ZJYL research dossier (written May 10, 2026 by gemini-2.0-flash); the other 8 are question templates that restate figures shown above. Figures in this section are not part of the source register.

What does the MoonshotScore mean for ZJYL?

ZJYL carries the MoonshotScore stated above — the Weak band. This is an educational research signal, not a buy or sell recommendation. The number comes from the five-pillar engine (business quality, financial safety, valuation, growth durability, momentum), re-ranked daily against sector peers.

Is ZJYL a good stock to buy?

Stock Expert AI does not rate ZJYL buy, sell or hold. Jin Medical International Ltd. carries a MoonshotScore, in the Weak band, a research rating against its peers rather than a forecast. Whether it fits is your call: check what it sells, whether it earns and what the price assumes. This is educational content, not investment advice.

What is the ZJYL stock price today?

The last price recorded for Jin Medical International Ltd. (ZJYL), with its trading session and source, is listed under Price & valuation on this page. It is a provider snapshot, not a live exchange feed, so check a brokerage quote before you trade.

What are the main risks for ZJYL?

The main risks for Jin Medical International Ltd. include intense competition from larger medical device manufacturers, regulatory changes in the healthcare sector, and economic downturns affecting consumer spending. The company's small market capitalization and high beta also contribute to its risk profile.

What are the key factors to evaluate for ZJYL?

Jin Medical International Ltd. (ZJYL) holds a MoonshotScore in the low range. To weigh it, start with the trailing P/E under Price & valuation on this page. These partnerships can also facilitate access to new customer segments and generate recurring revenue streams. Not financial advice.

How frequently does ZJYL data refresh on this page?

ZJYL's price is the last quote we recorded, from the Nov 19, 2026 trading session. Pages are served from a cache, so the copy you are reading can lag that quote. The quote is a provider snapshot, not an exchange feed. Fundamentals follow quarterly filings. V2 is recalculated from the most recent completed US trading session; the score's own date shows its last successful run.

What has driven ZJYL's recent stock price performance?

Jin Medical International Ltd. (ZJYL) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Specialized in wheelchair and living aid products. See the News tab for the latest drivers. Past performance does not predict future results.

Should investors consider ZJYL overvalued or undervalued right now?

The trailing P/E of Jin Medical International Ltd. (ZJYL) is listed under Price & valuation on this page. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.

Can I buy fractional shares of ZJYL?

Fractional-share availability for Jin Medical International Ltd. (ZJYL) depends on your brokerage, account and supported securities. Check the broker's current eligibility, minimums and fees before placing an order.

Machine-generated analysis by Stock Expert AI — model gemini-2.0-flash, generated May 10, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief.

Sources: the source register lists the 12 figures on this page — 9 from Financial Modeling Prep (FMP), 2 with no recorded source and 1 from Stock Expert AI's own score and rank. Its rows (value as shown, as-of date, tier and source link) are in the Markdown version of this page.

Publication details and research sources
Published
Research standards
Methodology · Editorial policy · Corrections
Data Sources & Methodology
Figures come from Financial Modeling Prep (FMP). If FMP has no figure for a ticker, a price or fundamental may come from a Yahoo Finance fallback, or a price from an Alpaca fallback. SEC EDGAR is used only for filing links and company identity details (legal name, address), never for figures. AI analysis by Stock Expert AI proprietary algorithms. Technical indicators via industry-standard calculations. Last updated: .
Data Provenance
Sources: Financial Modeling Prep (FMP) — Primary · Yahoo Finance — Fallback · Alpaca — Tertiary
Last fetched:
Cache TTL: Quote 5min · Profile 7d · Financials 7d · Insider 48h
How we use AI: Numbers are pulled directly from FMP & Yahoo Finance — our AI writes the analysis, it never edits the figures.